Clinical Trial Update: Travoprost Intraocular Implant + iStent Infinite vs. iStent Infinite Alone [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating whether adding a travoprost intraocular implant to the iStent Infinite provides advantages over iStent Infinite alone in open-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• Travoprost intraocular implant (travoprost)
• iStent Infinite

Snippet

Sponsor: Glaukos Corporation | Conditions: Glaucoma, Open-Angle | Phase 3 | Status: RECRUITING